Axq Capital, LP Incyte Corp Transaction History

Axq Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $1 Million - $1.25 Million	-19,566 Reduced 54.51%	16,331 $990 Million
Q1 2024 May 14, 2024	BUY	$56.55 - $66.59 $1.85 Million - $2.18 Million	32,697 Added 1021.78%	35,897 $2.05 Billion
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $1 Million - $1.23 Million	-19,200 Reduced 85.71%	3,200 $201 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $1.29 Million - $1.48 Million	22,400 New	22,400 $1.29 Billion

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.